(ASIX) AdvanSix - Ratings and Ratios
Nylon,Caprolactam,Fertilizer,Acetone,Chemicals
ASIX EPS (Earnings per Share)
ASIX Revenue
Description: ASIX AdvanSix October 22, 2025
AdvanSix Inc. (NYSE:ASIX) manufactures and sells a range of polymer resins and specialty chemicals, most notably Nylon 6, which is used in fibers, engineered plastics, and films. Its product slate also includes caprolactam (the primary feedstock for Nylon 6), ammonium sulfate fertilizer, acetone, and a suite of intermediate chemicals such as phenol, cyclohexanone, and specialty amines, marketed under brands like Aegis, Sulf-N, Nadone, Naxol, and EZ-Blox. The company distributes directly and through third-party channels, serving both U.S. and international customers from its Parsippany, New Jersey headquarters.
Key operational metrics that analysts watch include: (1) 2023 revenue of roughly $1.2 billion with an adjusted EBITDA margin near 13%, reflecting relatively high profitability for a commodity chemicals producer; (2) caprolactam price volatility, which historically drives up to 30% of Nylon 6 cost-structure and is closely linked to global crude oil and natural gas prices; and (3) capacity utilization at its primary plant, typically hovering around 85%, a level that can be constrained by feedstock supply or regulatory limits on emissions. Macro-level drivers such as rising demand for lightweight automotive components and sustainable packaging are expected to boost Nylon 6 consumption, while higher energy costs could pressure margins across the broader commodity chemicals sector.
If you want a data-rich, quantitative deep-dive into ASIX’s valuation and risk profile, the ValueRay platform offers tools that can help you model those dynamics more precisely.
ASIX Stock Overview
| Market Cap in USD | 499m |
| Sub-Industry | Commodity Chemicals |
| IPO / Inception | 2016-10-03 |
ASIX Stock Ratings
| Growth Rating | -72.0% |
| Fundamental | 40.7% |
| Dividend Rating | 75.4% |
| Return 12m vs S&P 500 | -47.1% |
| Analyst Rating | - |
ASIX Dividends
| Dividend Yield 12m | 3.44% |
| Yield on Cost 5y | 4.44% |
| Annual Growth 5y | 72.35% |
| Payout Consistency | 100.0% |
| Payout Ratio | 29.3% |
ASIX Growth Ratios
| Growth Correlation 3m | -10% |
| Growth Correlation 12m | -83.5% |
| Growth Correlation 5y | -38.2% |
| CAGR 5y | -18.83% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.33 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.60 |
| Sharpe Ratio 12m | -2.60 |
| Alpha | -60.64 |
| Beta | 1.643 |
| Volatility | 35.74% |
| Current Volume | 384.4k |
| Average Volume 20d | 295.3k |
| Stop Loss | 17.7 (-4.8%) |
| Signal | 0.05 |
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (77.3m TTM) > 0 and > 6% of Revenue (6% = 90.9m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA 5.88pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 7.47% (prev 7.06%; Δ 0.40pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 154.0m > Net Income 77.3m (YES >=105%, WARN >=100%) |
| Net Debt (359.3m) to EBITDA (79.5m) ratio: 4.52 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.35 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (27.2m) change vs 12m ago 0.36% (target <= -2.0% for YES) |
| Gross Margin 11.93% (prev 7.42%; Δ 4.51pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 96.98% (prev 101.2%; Δ -4.20pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.33 (EBITDA TTM 79.5m / Interest Expense TTM 8.89m) >= 6 (WARN >= 3) |
Altman Z'' 2.68
| (A) 0.07 = (Total Current Assets 434.2m - Total Current Liabilities 321.1m) / Total Assets 1.65b |
| (B) 0.41 = Retained Earnings (Balance) 677.4m / Total Assets 1.65b |
| (C) 0.00 = EBIT TTM 2.96m / Avg Total Assets 1.56b |
| (D) 0.83 = Book Value of Equity 683.7m / Total Liabilities 822.7m |
| Total Rating: 2.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 40.74
| 1. Piotroski 2.50pt = -2.50 |
| 2. FCF Yield 6.42% = 3.21 |
| 3. FCF Margin 3.63% = 0.91 |
| 4. Debt/Equity 0.46 = 2.40 |
| 5. Debt/Ebitda 4.52 = -2.50 |
| 6. ROIC - WACC (= -6.83)% = -8.54 |
| 7. RoE 9.79% = 0.82 |
| 8. Rev. Trend -32.40% = -2.43 |
| 9. EPS Trend -12.44% = -0.62 |
What is the price of ASIX shares?
Over the past week, the price has changed by -5.87%, over one month by -4.13%, over three months by -0.88% and over the past year by -35.91%.
Is AdvanSix a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ASIX is around 15.90 USD . This means that ASIX is currently overvalued and has a potential downside of -14.47%.
Is ASIX a buy, sell or hold?
What are the forecasts/targets for the ASIX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 28 | 50.6% |
| Analysts Target Price | 28 | 50.6% |
| ValueRay Target Price | 17.5 | -5.8% |
ASIX Fundamental Data Overview November 01, 2025
P/E Trailing = 6.5423
P/S = 0.3292
P/B = 0.6319
Beta = 1.643
Revenue TTM = 1.52b USD
EBIT TTM = 2.96m USD
EBITDA TTM = 79.5m USD
Long Term Debt = 240.0m USD (from longTermDebt, last quarter)
Short Term Debt = 38.7m USD (from shortTermDebt, last quarter)
Debt = 377.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 359.3m USD (from netDebt column, last quarter)
Enterprise Value = 858.1m USD (498.8m + Debt 377.8m - CCE 18.4m)
Interest Coverage Ratio = 0.33 (Ebit TTM 2.96m / Interest Expense TTM 8.89m)
FCF Yield = 6.42% (FCF TTM 55.1m / Enterprise Value 858.1m)
FCF Margin = 3.63% (FCF TTM 55.1m / Revenue TTM 1.52b)
Net Margin = 5.10% (Net Income TTM 77.3m / Revenue TTM 1.52b)
Gross Margin = 11.93% ((Revenue TTM 1.52b - Cost of Revenue TTM 1.33b) / Revenue TTM)
Gross Margin QoQ = 14.32% (prev 14.15%)
Tobins Q-Ratio = 0.52 (Enterprise Value 858.1m / Total Assets 1.65b)
Interest Expense / Debt = 0.60% (Interest Expense 2.25m / Debt 377.8m)
Taxrate = 0.88% (279.0k / 31.6m)
NOPAT = 2.94m (EBIT 2.96m * (1 - 0.88%))
Current Ratio = 1.35 (Total Current Assets 434.2m / Total Current Liabilities 321.1m)
Debt / Equity = 0.46 (Debt 377.8m / totalStockholderEquity, last quarter 823.7m)
Debt / EBITDA = 4.52 (Net Debt 359.3m / EBITDA 79.5m)
Debt / FCF = 6.52 (Net Debt 359.3m / FCF TTM 55.1m)
Total Stockholder Equity = 789.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.70% (Net Income 77.3m / Total Assets 1.65b)
RoE = 9.79% (Net Income TTM 77.3m / Total Stockholder Equity 789.8m)
RoCE = 0.29% (EBIT 2.96m / Capital Employed (Equity 789.8m + L.T.Debt 240.0m))
RoIC = 0.29% (NOPAT 2.94m / Invested Capital 1.01b)
WACC = 7.12% (E(498.8m)/V(876.5m) * Re(12.07%) + D(377.8m)/V(876.5m) * Rd(0.60%) * (1-Tc(0.01)))
Discount Rate = 12.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.62%
[DCF Debug] Terminal Value 54.71% ; FCFE base≈55.1m ; Y1≈36.2m ; Y5≈16.5m
Fair Price DCF = 7.23 (DCF Value 194.1m / Shares Outstanding 26.8m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -12.44 | EPS CAGR: -31.45% | SUE: -4.0 | # QB: 0
Revenue Correlation: -32.40 | Revenue CAGR: -5.48% | SUE: 4.0 | # QB: 2
Additional Sources for ASIX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle